Sort   by:  
 Page size 
0
UnknownInnate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
Not available
S-EPMC8822242 | biostudies-literature
0
UnknownGold Nanoparticle-Coated ZrO₂-Nanofiber Surface as a SERS-Active Substrate for Trace Detection of Pesticide Residue.
Not available
S-EPMC6027227 | biostudies-literature
0
UnknownPreliminary Assessment of Burn Depth by Paper-Based ELISA for the Detection of Angiogenin in Burn Blister Fluid-A Proof of Concept.
Not available
S-EPMC7151184 | biostudies-literature
0
UnknownPSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2.
Not available
S-EPMC5995171 | biostudies-literature
0
UnknownAge Specific Risks of Uterine Cancer in Type 2 Diabetes and Associated Comorbidities in Taiwan.
Not available
S-EPMC9564306 | biostudies-literature
0
UnknownA Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis.
Not available
S-EPMC5868173 | biostudies-literature
0
UnknownPre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination.
Not available
S-EPMC10124102 | biostudies-literature
0
UnknownXPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer.
Not available
S-EPMC10252687 | biostudies-literature
0
UnknownSafety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study.
Not available
S-EPMC8108062 | biostudies-literature
0
UnknownThe Effect of the Chorion on Size-Dependent Acute Toxicity and Underlying Mechanisms of Amine-Modified Silver Nanoparticles in Zebrafish Embryos.
Not available
S-EPMC7215958 | biostudies-literature
Sort   by:  
 Page size